Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
Zoledronic Acid: Clinical Uses, Therapeutic Effects and Pharmacokinetics

Zoledronic Acid: Clinical Uses, Therapeutic Effects and Pharmacokinetics

9781633215252
1,140.24 zł
1,026.21 zł Save 114.03 zł Tax included
Lowest price within 30 days before promotion: 1,026.21 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Zoledronic acid is a third generation bisphosphonate which is administered intravenously once yearly at a dose of 5mg for multiple reasons including the treatment of post-menopausal women with osteoporosis to reduce the incidence of vertebral, hip and non-vertebral fractures and to increase bone mineral density (BMD), the prevention of clinical fractures after hip fracture in women and men, treatment of osteoporosis in men, prevention and treatment of glucocorticoid-induced osteoporosis (GIO), the prevention of post-menopausal osteoporosis (in the US) and the treatment of Pagets disease of the bone. This book discusses the clinical uses, therapeutic effects and pharmacokinetics of zoledronic acid.
Product Details
Nova Science Publishers Inc
74648
9781633215252
9781633215252

Data sheet

Publication date
2014
Issue number
1
Cover
hard cover
Pages count
266
Dimensions (mm)
178.00 x 254.00
Weight (g)
598
  • PrefaceUse of Zoledronic Acid in Men and Women with Low Bone Mass(Robin K. Dore, Clinical Professor of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA)Clinical and Experimental Evidences of Anti-Myeloma Activities of Zoledronic Acid(R. Ria, A. Reale, A. Melaccio, A. Vacca, Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy)The Use of Zoledronic Acid in Osteoarthritis:: From Animal Models to Clinical Studies(Nidhi Sofat, Anasuya Kuttapitiya, Toby Smith, Institute of Infection and Immunity, St. Georges University of London, Cranmer Terrace, London, UK, and others)Treatment with Zoledronic Acid in Pagets Disease of Bone(Javier Bachiller-Corral, Walter Alberto Sifuentes-Giraldo, Department of Rheumatology, University Hospital Ramón y Cajal, Madrid, Spain)For Complete Table of Contents, please visit our website athttps:://www.novapublishers.com/catalog/product_info.php?products_id=50682
Comments (0)
Viewed products

  • Frequently purchased together

    No products available